Healthy Japanese adult people
Conditions
Interventions
Duration: 4 weeks Follow-up duration: 2 weeks Test material: Calcium-blended lemon beverage Dosage: Drink 3 bottles (350 mL per bottle) of test beverage per day in 3 separate times at any time of t
Sponsors
ORTHOMEDICO Inc.
Medical Corporation Seishinkai, Takara Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese adult people 2. Subjects who are judged as eligible to participate in the study by the physician
Exclusion criteria
Exclusion criteria: 1. A medical history of malignant tumor, heart failure or myocardial infarction 2. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver failure, kidney failure, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 3. Subjects who have a medical history of calculus 4. Subjects who are under the treatment of osteoporosis 5. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 6. Currently taking medicines (include herbal medicines) and supplements 7. Subjects who take fortified food/beverage with calcium in daily 8. Subjects who are allergic to medicines and/or the test beverage related products 9. Subjects who was on medication for hay fever for the last 3 years 10. Subjects who are pregnant, lactation, and planning to become pregnant 11. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 12. Subjects who are judged as ineligible to participate in the study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Physical examination 2. Urinalysis 3. Blood test 4. Subjective symptoms (the Likert scale) * Assess at screening and examination before consuming, at 2 and 4 weeks after ingestion, and follow-up period for 2 weeks | — |
Countries
Japan
Contacts
Public ContactNaoko SUZUKI
ORTHOMEDICO Inc. R&D Department
Outcome results
None listed